Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorMuiño, Elena
dc.contributor.authorMaisterra Santos, Olga
dc.contributor.authorJimenez Balado, Joan
dc.contributor.authorCullell, Natalia
dc.contributor.authorCarrera, Caty
dc.contributor.authorTorres‑Aguila, Nuria P.
dc.date.accessioned2021-11-15T11:45:03Z
dc.date.available2021-11-15T11:45:03Z
dc.date.issued2021-03-25
dc.identifier.citationMuiño E, Maisterra O, Jiménez-Balado J, Cullell N, Carrera C, Torres-Aguila NP, et al. Genome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment. Sci Rep. 2021 Mar 25;11:6846.
dc.identifier.issn2045-2322
dc.identifier.urihttp://hdl.handle.net/11351/6545
dc.descriptionDemència; Mal de cap; Ictus
dc.description.sponsorshipThis work was supported by a grant from the Carlos III Health Institute (PI 11/0176), Generación Project, Maestro Project, INVICTUS + network, Epigenesis Project (Marató de TV3), FEDER funds and economic donations from “Asociación CADASIL España”. E. Muiño is supported by a Río Hortega Contract (CM18/00198) from the Carlos III Health Institute. J. Cárcel-Márquez is supported by an AGAUR Contract (agència de gestió d'ajuts universitaris i de recerca; FI_DGR 2019, grant number 2019_FI_B 00853) co-financed with Fons Social Europeu (FSE). M. Lledós is supported by a PFIS Contract (Contratos Predoctorales de Formación en Investigación en Salud) from the Carlos III Health Institute.
dc.language.isoeng
dc.publisherNature Research
dc.relation.ispartofseriesScientific Reports;11
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectTrastorns de la cognició
dc.subjectTranscriptomes
dc.subject.meshTranscriptome
dc.subject.meshCognitive Dysfunction
dc.subject.mesh/pathology
dc.titleGenome-wide transcriptome study in skin biopsies reveals an association of E2F4 with cadasil and cognitive impairment
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1038/s41598-021-86349-1
dc.subject.decstranscriptoma
dc.subject.decsdisfunción cognitiva
dc.subject.decs/patología
dc.relation.publishversionhttps://doi.org/10.1038/s41598-021-86349-1
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Muiño E, Carrera C, Torres-Aguila NP] Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Maisterra O, Jiménez-Balado J] Laboratori de Recerca Neurovascular, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Cullell N] Stroke Pharmacogenomics and Genetics Group, Institut de Recerca de l`Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Stroke Pharmacogenomics and Genetics, Fundació MútuaTerrassa per la Docència i la Recerca, Terrassa, Spain
dc.identifier.pmid33767277
dc.identifier.wos000635699600007
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/CM18%2F00198
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple